Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing innovative treatments for ...

Earendil Labs, an expert in AI-driven research and development of next-generation biologics therapeutics, and Sanofi have ...

Ziihera, a therapeutic antibody developed using ProBioGen's proprietary GlymaxX technology, has become commercially available ...

Bristol Myers Squibb’s Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with ...

Both companies will work to revolutionize cell culture media in biotech and the vaccine industry with animal-free, high-yield ...

Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Thermo Fisher Scientific Inc. has introduced the 5L DynaDrive Single-Use Bioreactor, expanding the company's portfolio of ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

Arcutis Biotherapeutics Inc. has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the ...

Rivus Pharmaceuticals, Inc., announced the expansion of its leadership team and the opening of a South San Francisco office ...

Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has appointed Thomas ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...